IL2RA and myeloid sarcoma: Our study also found that a higher percentage of CD25++CD8br T cell in T cell and a higher percentage of CD25++CD8br T cell in CD8br T cell decreased the risk of MS and have the potential to alleviate MS severity, respectively.